CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/438357534c28d951ab3d87fdef045646.pdf

Abstract Title

First Name *

Radko

Last Name *

Komers

Co-author 1

Laura Kooienga lkooienga@cokidneycare.com Colorado Kidney Care Research Division Denver

Co-author 2

Robert Malecki robert.malecki@aol.pl Międzyleski Specialist Hospital Department of Nephrology Warsaw

Co-author 3

Alex Mercer alex.mercer@travere.com JAMCO Pharma Consulting N/A Stockholm

Co-author 4

Nuhira Ahmed Masthan Ahmed Nuhira.Masthan@travere.com Travere Therapeutics, Inc. Biostatistics San Diego

Co-author 5

Priscila Preciado Priscila.preciado@travere.com Travere Therapeutics, Inc. Clinical Development, Nephrology San Diego

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15